-
Upcoming events
DCVA & RegMed XB Community Event
For academic researchers and healthcare innovators interested in valorization, entrepreneurship, and accelerating from lab to patient.
read more
RegMed XB Annual Conference 2026
Be part of the 4th RegMed XB Annual Conference: Collaborate to Regenerate. Get inspired and expand your network within the regenerative medicine field.
read more -
Expertise
Infrastructure: RegMed XB's Pilot Factory
A seamless pathway for innovators to accelerate, de-risk, and scale regenerative therapies
read more
-
Latest news
Still Millions Available for Health & Care Innovations through the National Growth Fund
Although the National Growth Fund has officially concluded following its third round of funding, several million euros remain available for promising new initiatives—especially in the field of Health & Care.
read more
Hello R&D sets out to eliminate liver toxicity
Liver toxicity is the number one reason for drugs to be retracted from the market. More reliable methods for predicting drug- induced liver toxicity will not only save drug development costs by detecting liver toxic drugs earlier, but will also spare patients from potential severe side effects due to liver toxicity.
read more
RegMed XB CEO Bernard Mulder had the honor of meeting His Majesty King Willem-Alexander
On May 22, our General Director Bernard Mulder had the honor of joining His Majesty King Willem-Alexander of the Kingdom of the Netherlands, Prof. Yoshiki Sawa, Chairman of the Organization for Advanced Healthcare Innovation (Nakanoshima Qross), and H.E. Ms. Reinette Klever, Minister for Foreign Trade and Development Cooperation of the Netherlands.
read more -
Moonshots (research excellence)
-
Pilot Factory (infrastructure)
The RegMed XB Pilot Factory is one of the largest international infrastructures for regenerative medicine. It brings together all the expertise and infrastructure needed to bring regenerative medicine to the market.
-
RegMed XB's Ecosystem
Health Foundations
The following Dutch health foundations are involved in defining research objectives and provide guidance in the research we conduct to ensure we maintain focus on the patient.
read moreAcademic Partners
RegMed XB works together with (inter)national top-rated academic institutions and collaborates specifically and exclusively with researchers who contribute specific expertise to the Moonshot initiatives.
read moreIndustrial Partners
Partnering with companies offers access to their expertise in designing scalable and feasible products. Currently, we have strong partnerships with the following entities.
read moreGovernmental Partners
RegMed XB receives support from national and local governments to de-risk promising concepts from academia to proof of concept or initial clinical trial stages.
read moreLife Science & Health partners
The following Life Science & Health (LSH) partners are collaborate with RegMed XB.
read more -
-
-
-
-
-
-
-
-
